Relationship between global leadership initiative on malnutrition (GLIM) defined malnutrition and survival, length of stay and post-operative complications in people with cancer: A systematic review.


Journal

Clinical nutrition (Edinburgh, Scotland)
ISSN: 1532-1983
Titre abrégé: Clin Nutr
Pays: England
ID NLM: 8309603

Informations de publication

Date de publication:
03 2023
Historique:
received: 25 10 2022
revised: 11 12 2022
accepted: 09 01 2023
pubmed: 31 1 2023
medline: 3 3 2023
entrez: 30 1 2023
Statut: ppublish

Résumé

The predictive validity of the GLIM criteria for survival, length of hospital stay (LOHS) and post-operative complications among people with cancer have not been systematically reviewed. This systematic review aims to determine whether GLIM malnutrition is predictive of these outcomes, and whether the predictive validity is affected by how phenotypic and etiologic criteria are assessed. Cohort studies published after 2018 were systematically reviewed according to PRISMA guidelines from Embase, Medline Complete and CINAHL Complete. Risk of bias and methodologic quality were assessed using the Journal of the Academy of Nutrition and Dietetics' Quality Criteria Checklist tool for Primary research. In total, 21 studies were included, including 28,726 participants. All studies investigated survival, where 18 reported GLIM malnutrition is associated with decreased survival. LOHS was investigated in six studies, with all finding an association between GLIM malnutrition and longer LOHS. Post-operative complications were assessed in seven studies, of which five reported GLIM malnutrition was predictive of increased post-operative complications. Methods to assess the GLIM phenotypic and etiologic criteria varied, with consistent predictive ability for survival regardless of method of assessing reduced muscle mass. However, predictive ability was more variable across different measures of inflammation and reduced intake. GLIM malnutrition was consistently predictive of worse clinical outcomes. Different measures of reduced muscle mass did not affect the predictive ability of GLIM for survival. However, variation in assessment of the etiologic criteria resulted in varying predictive ability of the GLIM diagnosis for survival.

Sections du résumé

BACKGROUND & AIMS
The predictive validity of the GLIM criteria for survival, length of hospital stay (LOHS) and post-operative complications among people with cancer have not been systematically reviewed. This systematic review aims to determine whether GLIM malnutrition is predictive of these outcomes, and whether the predictive validity is affected by how phenotypic and etiologic criteria are assessed.
METHODS
Cohort studies published after 2018 were systematically reviewed according to PRISMA guidelines from Embase, Medline Complete and CINAHL Complete. Risk of bias and methodologic quality were assessed using the Journal of the Academy of Nutrition and Dietetics' Quality Criteria Checklist tool for Primary research.
RESULTS
In total, 21 studies were included, including 28,726 participants. All studies investigated survival, where 18 reported GLIM malnutrition is associated with decreased survival. LOHS was investigated in six studies, with all finding an association between GLIM malnutrition and longer LOHS. Post-operative complications were assessed in seven studies, of which five reported GLIM malnutrition was predictive of increased post-operative complications. Methods to assess the GLIM phenotypic and etiologic criteria varied, with consistent predictive ability for survival regardless of method of assessing reduced muscle mass. However, predictive ability was more variable across different measures of inflammation and reduced intake.
CONCLUSION
GLIM malnutrition was consistently predictive of worse clinical outcomes. Different measures of reduced muscle mass did not affect the predictive ability of GLIM for survival. However, variation in assessment of the etiologic criteria resulted in varying predictive ability of the GLIM diagnosis for survival.

Identifiants

pubmed: 36716618
pii: S0261-5614(23)00014-6
doi: 10.1016/j.clnu.2023.01.012
pii:
doi:

Types de publication

Systematic Review Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

255-268

Informations de copyright

Copyright © 2023 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of interest Dr. Kiss reports grants from Medical Nutrition Industry, grants from Medical Research Future Fund, grants from AuSPEN, grants from Amgen OA-ANZBMS, grants from Victorian Cancer Agency, outside the submitted work.

Auteurs

Dylan Brown (D)

School of Exercise and Nutrition Sciences, Deakin University, Geelong, Australia.

Jenelle Loeliger (J)

School of Exercise and Nutrition Sciences, Deakin University, Geelong, Australia; Nutrition and Speech Pathology Department, Peter MacCallum Cancer Centre, Melbourne, Australia.

Jane Stewart (J)

Nutrition and Speech Pathology Department, Peter MacCallum Cancer Centre, Melbourne, Australia.

Kate L Graham (KL)

Nutrition and Speech Pathology Department, Peter MacCallum Cancer Centre, Melbourne, Australia.

Sunita Goradia (S)

School of Exercise and Nutrition Sciences, Deakin University, Geelong, Australia.

Chantal Gerges (C)

School of Exercise and Nutrition Sciences, Deakin University, Geelong, Australia.

Shania Lyons (S)

School of Exercise and Nutrition Sciences, Deakin University, Geelong, Australia.

Molly Connor (M)

School of Exercise and Nutrition Sciences, Deakin University, Geelong, Australia.

Sam Stewart (S)

School of Exercise and Nutrition Sciences, Deakin University, Geelong, Australia.

Adrian Di Giovanni (A)

School of Exercise and Nutrition Sciences, Deakin University, Geelong, Australia.

Sarah D'Angelo (S)

School of Exercise and Nutrition Sciences, Deakin University, Geelong, Australia.

Nicole Kiss (N)

Institute for Physical Activity and Nutrition, Deakin University, Geelong, Australia; Allied Health Department, Peter MacCallum Cancer Centre, Melbourne, Australia. Electronic address: nicole.kiss@deakin.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH